Heidelberg, Germany
Luxendo, a spin-out from the European Molecular Biology Laboratory (EMBL) founded in 2015, excels in the realm of light-sheet microscopy. Notably, their proprietary microscopy solutions emphasize ease of use and application flexibility, empowering scientists globally in their research endeavors. The company offers a range of innovative products such as the MuVi SPIM for versatile imaging, TruLive3D Imager for multiplex 3D imaging, and the InVi SPIM Lattice Pro for high-resolution imaging.
Based in Germany, Luxendo operates within the Biotechnology, Manufacturing, and Clean Energy industries. Their solutions help avoid sample phototoxicity, enabling extended observation of living organisms—essential for scientific progress.
Luxendo became part of Bruker Corp. through an acquisition investment on 01 May 2017. The acquisition bolstered Luxendo's capabilities within Bruker’s Nano Surfaces Division, enhancing R&D synergies and market access. For investors, Luxendo represents a unique fusion of cutting-edge microscopy innovation and strategic industry positioning.
